Published in

Springer Nature [academic journals on nature.com], Oncogene, 3(32), p. 397-402, 2012

DOI: 10.1038/onc.2012.56

Links

Tools

Export citation

Search in Google Scholar

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity

Journal article published in 2012 by L. van der Weyden, A. G. Rust, R. E. McIntyre, C. D. Robles-Espinoza, M. del Castillo Velasco-Herrera, R. Strogantsev, A. C. Ferguson-Smith, S. McCarthy ORCID, T. M. Keane, M. J. Arends, D. J. Adams
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

We performed a genetic screen in mice to identify candidate genes that are associated with leukaemogenesis in the context of Trp53 heterozygosity. To do this we generated Trp53 heterozygous mice carrying the T2/Onc transposon and SB11 transposase alleles to allow transposon-mediated insertional mutagenesis to occur. From the resulting leukaemias/lymphomas that developed in these mice, we identified nine loci that are potentially associated with tumour formation in the context of Trp53 heterozygosity, including AB041803 and the Jun dimerization protein 2 (Jdp2). We show that Jdp2 transcriptionally regulates the Trp53 promoter, via an atypical AP-1 site, and that Jdp2 expression negatively regulates Trp53 expression levels. This study is the first to identify a genetic mechanism for tumour formation in the context of Trp53 heterozygosity.Oncogene advance online publication, 27 February 2012; doi:10.1038/onc.2012.56.